|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,978.10 INR | +0.43% |
|
+4.54% | +44.97% |
| Market Cap | 38TCr 394.26Cr 342.33Cr 319.18Cr 293.22Cr 554.55Cr 560.63Cr 3.76TCr 1.47TCr 19TCr 1.48TCr 1.45TCr 62TCr | P/E 2026 |
32.7x | P/E 2027 * | 32.5x |
|---|---|---|---|---|---|
| Enterprise Value | 38TCr 401.35Cr 348.49Cr 324.93Cr 298.49Cr 564.53Cr 570.72Cr 3.83TCr 1.5TCr 19TCr 1.51TCr 1.47TCr 63TCr | EV / Sales 2026 |
3.33x | EV / Sales 2027 * | 3.64x |
| Free-Float |
18.3% | Yield 2026 |
0.23% | Yield 2027 * | 0.19% |
Last Transcript: Emcure Pharmaceuticals Limited
| 1 day | +0.43% | ||
| 1 week | +4.54% | ||
| Current month | +0.92% | ||
| 1 month | +7.56% | ||
| 3 months | +10.31% | ||
| 6 months | +28.87% | ||
| Current year | +44.97% |
| 1 week | 1,900 |  | 1,999 |
| 1 month | 1,751 | | 1,999 |
| Current year | 1,381 | | 1,999 |
| 1 year | 1,260 | | 1,999 |
| 3 years | 889 | | 1,999 |
| 5 years | 889 | | 1,999 |
| 10 years | 889 | | 1,999 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/1981 | |
| Director of Finance/CFO | - | 01/10/2003 | |
| Compliance Officer | - | 04/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
| Director/Board Member | 73 | 23/07/2001 | |
| Director/Board Member | 75 | 16/04/1981 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.43% | +4.54% | +40.20% | - | 391.79Cr | |
| -0.51% | -8.60% | +45.08% | +148.21% | 1LCr | |
| +0.20% | -4.42% | +49.05% | +50.81% | 61TCr | |
| -0.53% | -7.37% | +23.64% | +65.03% | 43TCr | |
| +0.48% | -2.77% | +40.27% | +34.96% | 35TCr | |
| +0.08% | -4.45% | +31.74% | +39.89% | 29TCr | |
| +2.09% | -9.27% | +5.42% | +7.61% | 24TCr | |
| +1.75% | -8.29% | -1.73% | -42.05% | 21TCr | |
| +2.94% | -0.78% | +29.17% | +60.32% | 20TCr | |
| +3.13% | +0.69% | +18.11% | +71.90% | 16TCr | |
| Average | +1.10% | -3.74% | +28.10% | +48.52% | 35.04TCr | |
| Weighted average by Cap. | +0.72% | -5.58% | +33.89% | +71.02% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 9.16TCr 96Cr 84Cr 78Cr 72Cr 135.38Cr 136.87Cr 918.69Cr 359.14Cr 4.58TCr 361.46Cr 353.53Cr 15TCr | 10TCr 109.76Cr 95Cr 89Cr 82Cr 154.39Cr 156.08Cr 1.05TCr 409.55Cr 5.22TCr 412.2Cr 403.16Cr 17TCr |
| Net income | 981.06Cr 10Cr 8.96Cr 8.35Cr 7.67Cr 15Cr 15Cr 98Cr 38Cr 490.42Cr 39Cr 38Cr 1.62TCr | 1.14TCr 12Cr 10Cr 9.73Cr 8.94Cr 17Cr 17Cr 114.74Cr 45Cr 571.64Cr 45Cr 44Cr 1.89TCr |
| Net Debt | 674.92Cr 7.1Cr 6.16Cr 5.74Cr 5.28Cr 9.98Cr 10Cr 68Cr 26Cr 337.38Cr 27Cr 26Cr 1.12TCr | 456.45Cr 4.8Cr 4.17Cr 3.88Cr 3.57Cr 6.75Cr 6.82Cr 46Cr 18Cr 228.17Cr 18Cr 18Cr 756.03Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | ₹1,978.10 | +0.43% | 1,03,614 |
| 03/26/03 | ₹1,969.70 | +0.49% | 1,16,048 |
| 31/26/31 | ₹1,960.10 | +2.57% | 2,67,249 |
| 30/26/30 | ₹1,910.90 | +0.38% | 73,582 |
| 29/26/29 | ₹1,903.70 | +0.61% | 87,477 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EMCURE Stock
Select your edition
All financial news and data tailored to specific country editions
